| [1] |
Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 180: Gestational Diabetes Mellitus [J]. Obstet Gynecol，2017，130(1): e17-e31.
|
| [2] |
Yuen L, Saeedi P, Riaz M, et al. Projections of the prevalence of hyperglycaemia in pregnancy in 2019 and beyond: Results from the International Diabetes Federation Diabetes Atlas, 9th edition [J]. Diabetes Res Clin Pract, 2019, 157：107841.
|
| [3] |
Zhu WW, Yang HX, Wang C, et al. High prevalence of gestational diabetes mellitus in Beijing: effect of maternal birth weight and other risk factors [J]. Chin Med J (Engl), 2017, 130(9)：1019-1025.
|
| [4] |
Gao C, Sun X, Lu L, et al. Prevalence of gestational diabetes mellitus in mainland China: A systematic review and meta-analysis [J]. J Diabetes Investig, 2019，10(1)：154-162.
|
| [5] |
Chamberlain JJ, Rhinehart AS, Shaefer CF，et al. Diagnosis and managment of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes [J]. Ann Int Med, 2016，164(8)：706-714.
|
| [6] |
Lee KW, Ching SM, Ramachandran V，et al. Prevalence and risk factors of gestational diabetes mellitus in Asia: a systematic review and meta-analysis [J]. BMC Pregnancy Childbirth, 2018, 18 (12)：494-513.
|
| [7] |
Santos S, Voerman E, Amiano P, et al. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts [J]. BJOG, 2019, 126(8)：984-995.
|
| [8] |
Hong S, Lee SM, Kwak SH, et al. A Comparison of Predictive Performances between Old versus New Criteria in a Risk-Based Screening Strategy for Gestational Diabetes Mellitus [J]. Diabetes Metab J, 2020, 44(5): 726-736.
|
| [9] |
HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes [J]. N Engl J Med, 2008, 358(19)：1991-2002.
|
| [10] |
Hillier TA, Pedula KL, Schmidt MM, et al. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia [J]. Diabetes Care, 2007, 30(9)：2287-2292.
|
| [11] |
Farrar D, Simmonds M, Bryant M, et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis [J]. BMJ, 2016, 354(9)：4694-4708.
|
| [12] |
Dong S, Wu H. Regenerating β cells of the pancreas-potential developments in diabetes treatment [J]. Expert Opin Biol Ther, 2018, 18(2)：175-185.
|
| [13] |
Nakano H, Minami I, Braas D, et al. Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis[J]. Elife, 2017, 6(12)：29330-29352.
|
| [14] |
Shlomit RM, Grace Y, Amit D, et al. First-trimester fasting hyperglycemia and adverse pregnancy outcomes [J]. Diabetes Care, 2009, 32(9)：1639-1643.
|
| [15] |
Pedersen J. Hyperglycaemia-hyperinsulinism theory and birthweight. ∥The pregnant diabetic and her newborn [M]. 2nd Ed. Baltimore: Williams & Wilkins, 1977：211-217.
|
| [16] |
Edlund H. Pancreatic organogenesis--developmental mechanisms and implications for therapy [J]. Nat Rev Genet, 2002，3(7)：524-532.
|
| [17] |
Bastidas-Ponce A, Scheibner K, Lickert H, et al. Cellular and molecular mechanisms coordinating pancreas development [J]. Development, 2017, 144(16): 2873-2888.
|
| [18] |
Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care [J]. Int J Gynaecol Obstet, 2015, 131(Suppl3)：S173-S211.
|
| [19] |
International association of diabetes and pregnancy study groups consensus panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy [J]. Diabetes Care, 2010，33(3)：676-682.
|
| [20] |
Agarwal MM, Boulvain M, Coetzee E, et al. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline [J]. Diabetes Res Clin Pract, 2014, 103(3): 341-363.
|
| [21] |
American Diabetes Association. Classification and diagnosis of diabetes [J]. Diabetes Care, 2017, 40(suppl 1)：S11-S24.
|
| [22] |
U．S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U．S. Preventive Services Task Force recommendation statement [J]. Ann Intern Med, 2014, 160(6)：414-420.
|
| [23] |
Seshiah V, Balaji V, Balaji MS, et al. Gestational diabetes mellitus manifests in all trimesters of pregnancy [J]. Diabetes Res Clin Pract, 2007, 77(3): 482-484.
|
| [24] |
Hosseini E, Janghorbani M, Shahshahan Z. Comparison of risk factors and pregnancy outcomes of gestational diabetes mellitus diagnosed during early and late pregnancy [J]. Midwifery, 2018, 66(11)：64-69.
|
| [25] |
Riskin-Mashiah S, Younes G, Damti A, et al. First-trimester fasting hyperglycemia and adverse pregnancy outcomes [J]. Diabetes Care, 2009, 32(9)：1639-1643.
|
| [26] |
Tomoka U, Maki Y, Megumi U, et al. Comparison of pregnancy outcomesbetween women withearly-onset andlate-onset gestational diabetesin a retrospective multi-institutional study in Japan [J]. J Diabetes Investig, 2020, 11(1)：216-222.
|
| [27] |
Liu B, Cai J, Xu Y, et al. Early diagnosed diabetes mellitus is associated with adverse pregnancy outcomes: a prospective cohort study [J]. J Clin Endocrinol Metab, 2020, 105(12): e4264-e4274.
|
| [28] |
Shang M, Lin L. IADPSG criteria for diagnosing gestational diabetes mellitus and predicting adverse pregnancy outcomes [J]. J Perinatol, 2014，34(2)：100-104.
|
| [29] |
Kim MH, Kwak SH, Kim SH, et al. Pregnancy outcomes of women additionally diagnosed as gestational diabetes by the International Association of the Diabetes and Pregnancy Study Groups Criteria [J]. Diabetes Metab J, 2019，43(6)：766-775.
|
| [30] |
Duran A, Sáenz S, Torrejón MJ, et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study [J]. Diabetes Care, 2014，37(9)：2442-2450.
|
| [31] |
Lee KH, Han YJ, Chung JH, et al. Treatment of gestational diabetes diagnosed by the IADPSG criteria decreases excessive fetal growth [J]. Obstet Gynecol Sci, 2020，63(1)：19-26.
|
| [32] |
American Diabetes Association. Management of diabetes in pregnancy: Standards of Medical Care in Diabetes-2020 [J]. Diabetes Care, 2020, 43(Suppl 1)：S183-S192.
|
| [33] |
Koivusalo SB, Rono K, Klemetti MM, et al. Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish Gestational Diabetes Prevention Study (RADIEL): a randomized controlled trial [J]. Diabetes Care, 2016, 39(1)：24-30.
|
| [34] |
Song C, Li J, Leng J, et al. Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomized controlled trials [J]. Obes Rev, 2016, 17(10): 960-969.
|
| [35] |
Sweeting AN, Ross GP, Hyett J, et al. Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment [J]. Diabetes Care, 2016, 39(1): 75-81.
|
| [36] |
Lorenzo-Almorós A, Hang T, Peiró C, et al. Predictive and diagnostic biomarkers forgestational diabetes and its associated metabolic and cardiovascular diseases [J]. Cardiovasc Diabetol, 2019, 18(1)：140-155.
|